2017
DOI: 10.1017/cjn.2017.45
|View full text |Cite
|
Sign up to set email alerts
|

Oblique Intrathecal Injection in Lumbar Spine Surgery: A Technical Note

Abstract: Oblique dural puncture was not associated with increased incidence of postoperative CSF leakage. This safe and reliable method of delivery of ITM should therefore be routinely considered in lumbar spine surgery.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
3
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 20 publications
0
3
0
Order By: Relevance
“…Care will be taken to tilt the needle upward to avoid cutting the ligaments and dural fibres. The approximate distance between the epidural space and the skin is typically 45–60 mm, but it may be longer in obese patients 40. The needle will be advanced step by step, and after an obvious breakthrough, the core needle will be removed to check for CSF outflow.…”
Section: Methods and Analysismentioning
confidence: 99%
See 1 more Smart Citation
“…Care will be taken to tilt the needle upward to avoid cutting the ligaments and dural fibres. The approximate distance between the epidural space and the skin is typically 45–60 mm, but it may be longer in obese patients 40. The needle will be advanced step by step, and after an obvious breakthrough, the core needle will be removed to check for CSF outflow.…”
Section: Methods and Analysismentioning
confidence: 99%
“…The approximate distance between the epidural space and the skin is typically 45–60 mm, but it may be longer in obese patients. 40 The needle will be advanced step by step, and after an obvious breakthrough, the core needle will be removed to check for CSF outflow. If CSF does not flow out, the core needle will be reinserted, and its orientation will be carefully adjusted (each adjustment will be recorded as an additional attempt).…”
Section: Methods and Analysismentioning
confidence: 99%
“…The mitogen-activated protein kinase (MEK1) inhibitor PD98059 (Cell Signaling Technology, EMD Millipore, Billerica, MA, USA), the CCR2 antagonist, RS504393 (Tocris Bioscience, Bristol, UK), CCL2 (R & D Systems, Minneapolis, MN, USA), and the selective blocker of the NMDAR GluN2B subunit, Ifenprodil, (Sigma, New York, NY) were used in this study. For intrathecal injection, under brief anesthesia with isoflurane a lumbar puncture was made at L5–L6 with a 30-gauge needle as previously described [ 20 ].…”
Section: Methodsmentioning
confidence: 99%